90Sr Therapy For Oral Squamous Cell Carcinoma In Two Cats

Veterinary Radiology and Ultrasound

Volumn 52, Issue 1, 2011, Pages 114-117

  Nagata, Koichi ^a   Selting, Kimberly A ^a   Cook, Cristi R ^a   Renschler, Metta ^a   Lattimer, Jimmy C ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Cats; Oral squamous cell carcinoma; Strontium

Indexed keywords

FELIDAE;

STRONTIUM;

ANIMAL; ANIMAL DISEASE; ANIMAL EUTHANASIA; ARTICLE; CASE REPORT; CAT; CAT DISEASE; MOUTH TUMOR; PATHOLOGY; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR RECURRENCE;

ANIMALS; CAT DISEASES; CATS; EUTHANASIA, ANIMAL; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SQUAMOUS CELL; RADIATION DOSAGE; STRONTIUM RADIOISOTOPES; TREATMENT OUTCOME;

EID: 79951872928     PISSN: 10588183     EISSN: 17408261     Source Type: Journal    
DOI: 10.1111/j.1740-8261.2010.01731.x     Document Type: Article

References (35)

1. Stebbins KE, Morse CC, Goldschmidt MH. Feline oral neoplasia: a ten-year survey. Vet Path 1989;26:121-128.
2. Dorn CR, Taylor DON, Schneider R. Sunlight exposure and risk of developing cutaneous and oral squamous cell carcinomas in white cats. J Natl Cancer Inst 1971;46: 1073-1078.
3. Snyder LA, Bertone ER, Jakowski RM, Dooner MS, Jennings-Ritchie J, Moore AS. P53 expression and environmental tobacco smoke exposure in feline oral squamous cell carcinoma. Vet Pathol 2004;41:209-214.
4. Dhaliwal RS, Kitchell BE, Marretta SM. Oral tumors in dogs and cats Part I. Diagn Clin Signs 1998;20:1011-1020.
5. Postorino Reeves NC, Turrel J, Withrow SJ. Oral squamous cell carcinoma in the cat. J Am Anim Hosp Assoc 1993;29:438-441.
6. Hutson CA, Willauer CC, Walder EJ, Stone JL, Klein MK. Treatment of mandibular squamous cell carcinoma in cats by use of mandibulectomy and radiotherapy: seven cases (1987-1989). J Am Vet Med Assoc 1992;201:777-781.
7. Hayes AM, Adams VJ, Scase TJ, Murphy S. Survival of 54 cats with oral squamous cell carcinoma in United Kingdom general practice. J Small Anim Pract 2007;48:394-399.
8. Fox LE, Robert C, Rosenthal RC, et al. Use of cis-bis-neodecanoato-trans-R, R-1, 2-diaminocyclohexane platinum (II), a liposomal cisplatin analogue, in cats with oral squamous cell carcinoma. Am J Vet Res 2000; 61:791-795.
9. Bregazzi VS, LaRue SM, Powers BE, Fettman MJ, Ogilvie GK, Withrow SJ. Response of feline oral squamous cell carcinoma to palliative radiation therapy. Vet Radiol Ultrasound 2001;42:77-79.
10. Jones PD, de Lorimier LP, Kitchell BE, Losonsky JM. Gemcitabine as a radiosensitizer for nonresectable feline oral squamous cell carcinoma. J Am Anim Hosp Assoc 2003;39:463-467.
11. Bostock DE. The prognosis in the cats bearing squamous cell carcinoma. J Small Anim Pract 1972;3:119-125.
12. Withrow SJ, Vail DM. Small animal clinical oncology, 4th ed. Saunders: Elsevier, 2007;384.
13. 90Sr ophthalmic applicators using radiochromic film. Med Dosim 2000;25:171-177.
14. 90Strontium plesiotherapy for feline squamous cell of the nasal planum. J Fel Med Surg 2006;8:169-176.
15. Hammond GM, Gordon IK, Theon AP, Kent MS. Evaluation of strontium Sr 90 for the treatment of superficial squamous cell carcinoma of the nasal planum in cats: 49 cases (1990-2006). J Am Vet Med Assoc 2007;231:736-741.
16. Van Vechten MK, Theon AP. Strontium-90 plesiotherapy for treatment of early squamous cell carcinomas of the nasal planum in 25 cats. Proceedings of the 13th Annual Veterinary Cancer Society Conference. 2006; 107-108
17. Donaldson D, Sansom J, Murphy S, Scase T. Multiple limbal haemangiosarcomas in a border collie dog: management by lamellar keratectomy/sclerectomy and strontium-90 beta plesiotherapy. J Small Anim Pract 2006;47:545-549.
18. Donaldson D, Sansom J, Adams V. Canine limbal melanoma: 30 cases (1992-2004). Part2. Treatment with lamellar resection and adjunctive strontium-90 beta plesiotherpay-efficacy and morbidity. Vet Ophthamol 2006;9:115-119.
19. Turrel JM, Farrelly J, Page RL, McEntee MC. Evaluation of strontium 90 irradiation in treatment of cutaneous mast cell tumors in cats: 35 cases (1992-2002). J Am Vet Med Assoc 2006;228:898-901.
20. Nemetz L, Broome M. Strontium-90 therapy for uropygial neoplasia. Proceedings the annual meeting of the association of avian veterinarians. 2004
21. Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium. Cancer (Philadelphia) 1953;6:963-968.
22. Copper MP, Braakhuis BJ, de Vries N, Van Dongen GA, Nauta JJ, Snow GB. A panel of biomarkers of carcinogenesis of the upper aerodigestive tract as potential intermediate endpoints in chemoprevention trials. Cancer (Philadelphia.) 1993;71:825-830.
23. Borczuk AC, Powell CA. Expression profiling and lung cancer development. Proc Am Thorac Soc 2007;4:127-132.
24. Frankilin WA, Gazdar AF, Haney J, Wistuba II, La Rosa FG, Kennedy T, Ritchey DM, Miller YE. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J Clin Invest 1997;100:2133-2137.
25. Prevo LJ, Sanchez CA, Galipeau PC, Reid BJ. P53-mutant clones and field effects in Barrett's esophagus. Cancer Res 1999;59:4784-4787.
26. Rosenthal AN, Ryan A, Hopster D, Jacobs IJ. Molecular evidence of a common clonal origin and subsequent divergent clonal evolution in vulval intraepithelial neoplasia, vulval squamous cell carcinoma and lymph node metastases. Int J Cancer 2002;99:549-554.
27. Chu TY, Shen CY, Lee HS, Liu HS. Monoclonality and surface lesion-specific microsatellite alterations in premalignant and malignant neoplasia of uterine cervix: a local field effect of genomic instability and clonal evolution. Genes Chromosomes Cancer 1999;24:127-134.
28. Jothy S, Slesak B, Harlozinska A, Lapinska J, Adamiak J, Rabczynski J. Field effect of human colon carcinoma on normal mucosa: relevance of carcinoembryonic antigen expression. Tumour Biol 1996;17:58-64.
29. Forsti A, Louhelainen J, Soderberg M, Wijstrom H, Hemminki K. Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer. Eur J Cancer 2001;37:1372-1380.
30. Takahashi T, Habuchi T, Kakehi Y, et al. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res 1998;58:5835-5841.
31. Stern RS, Bolshakov S, Nataraj AJ, Ananthaswamy HN. P53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet a-treated patients: evidence for heterogeneity and field cancerization. 2002;119:522-526.
32. Gupta T, Agarwal JP, Ghosh-Laskar S, Parikh PM, D'Cruz AK, Dinshaw KA. Radical radiotherapy with concurrent weekly cisplatin in loco-regionally advanced squamous cell carcinoma of the head and neck: a single-institution experience. Head Neck Oncol 2009;1:17, doi: DOI: 10.1186/1758-3284-1-17.
33. Penderson WA, Haraf JD, Witt ME, et al. Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue. Head Neck 2010, doi: DOI: 10.1002/hed.21360.
34. Fidel JL, Sellon RK, Houston RK, Wheller BA. A nine-day accelerated radiation protocol for feline squamous cell carcinoma. Vet Radiol Ultrasound 2007;48:482-485.
35. Perez AP, Brady LW. Principles and practice of radiation oncology, 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 419pp.